Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H16O2 |
Molecular Weight | 240.297 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(O)=O)C1=CC=C(C=C1)C2=CC=CC=C2
InChI
InChIKey=IYEPZNKOJZOGJG-UHFFFAOYSA-N
InChI=1S/C16H16O2/c1-2-15(16(17)18)14-10-8-13(9-11-14)12-6-4-3-5-7-12/h3-11,15H,2H2,1H3,(H,17,18)
DescriptionSources: https://www.genome.jp/dbget-bin/www_bget?drug:D06337
Sources: https://www.genome.jp/dbget-bin/www_bget?drug:D06337
Xenbucin is an antihyperlipidemic agent. Information about the current use of this agent is not available.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0008292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/13537882 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m1268
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
213-492-9
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
R3U09W4H4I
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
3442
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105601
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
3656
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
100000079373
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
SUB00102MIG
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
DTXSID80862486
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
13737
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
C66663
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
959-10-4
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY | |||
|
16316
Created by
admin on Fri Dec 15 15:58:10 GMT 2023 , Edited by admin on Fri Dec 15 15:58:10 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)